Long-acting muscarinic antagonists, as add-on therapy to inhaled corticosteroids, improve lung function parameters and reduce ...

This was a retrospective analysis of electronic pharmacy and medical claims from a commercial health plan located in the states of California, Texas, Oklahoma, Oregon, and Washington, with annual ...

With that, Theravance expects its lifetime value from the inhaler to come out to $1.52 billion. The drug stems from a 2002 ...

Ohtuvayre's rapid US launch boosts Verona's growth with Q1 2025 sales up 95%. Read more on VRNA stock's blockbuster potential ...

Some asthma therapy appeared to be less effective in Black children living in areas with high levels of nitrogen dioxide (NO2).

As-needed use of a metered-dose inhaler with albuterol plus budesonide (Airsupra) lowered the risk of severe exacerbations compared with albuterol alone for people with normally mild asthma, the ...

Topline results were announced from two phase 3 trials evaluating itepekimab in former smokers with inadequately controlled COPD.

Influential expert in respiratory medicine. Born on June 11, 1947, in Tshwane, South Africa, he died on Jan 18, 2025, in Cape Town, South Africa, aged 77 years.

in addition to standard of care therapy (inhaled corticosteroid [ICS] + long-acting beta 2-agonist [LABA]; or long-acting muscarinic antagonist [LAMA] + LABA; or maximal standard of care inhaled ...

A development economist has warned that environmental pollution combined with the soaring cost of essential medications is significantly worsening the asthma crisis in the country.

As the world grapples with chronic respiratory diseases, asthma profoundly impacts millions of lives. Characterized by ...

Enerzair (formerly QVM149) consists of long-acting beta agonist (LABA) indacaterol, long-acting muscarinic antagonist (LAMA) glycopyrronium, and inhaled corticosteroid (ICS) mometasone furoate ...